Purchase Order 75N95023P00526

Award Date 8/9/23
Potential Completion Date 9/9/23
Potential Value $121K
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pleasanton, CA 94588, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $26,520.50 firm fixed price purchase order to 10X Genomics, Inc. for 10X multiple kits for genomics 5 GEMS library preparation. The place of performance is Pleasanton, California. The period of performance is from August 17, 2023 through August 22, 2023. This purchase order was awarded under an existing NIH vehicle to support the agency's genomics research...
This firm fixed price purchase order was awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, to 10X Genomics, Inc. The $22,871.25 contract provides 10X Genomics' specialized kits, instruments, and services to support single-cell and spatial analysis research, particularly in the areas of neurological diseases and disorders. 10X Genomics, as a prime contractor, has previously received...
This is a $23,518.67 fixed-price purchase order contract awarded by the National Institute on Deafness and Other Communication Disorders, a civilian agency within the National Institutes of Health, to 10X Genomics, Inc., a biotechnology company in Pleasanton, California. The contract is for the supply of GEM-X Universal 3' Gene Expression V4 kits, which are used for single-cell RNA sequencing analysis. This contract is not a set-aside and is part of the National Institute on Aging's larger...
The Department of Health and Human Services' National Institutes of Health's National Institute of Neurological Disorders and Stroke awarded a $25,000 purchase order to 10X Genomics, Inc. for single-cell RNA sequencing and ATAC sequencing reagents. The firm fixed price order is for the delivery of 10X Genomics reagents to support these genomic techniques at the agency's location in Pleasanton, California. Performance will take place from August to November 2023. No set aside designation or...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to 10X Genomics, Inc. for the supply of 10X Genomics reagents. The contract has a ceiling value of $42,000.00 and a period of performance through September 30, 2024. 10X Genomics, a for-profit manufacturer, is the prime contractor and no set-aside designation was used. The contract supports the NIH's research efforts, specifically in the area of neurological diseases and disorders. The...
The National Institutes of Health's National Institute of Neurological Disorders and Stroke awarded a $13,446.50 firm fixed price blanket purchase agreement call contract to 10X Genomics, Inc. of Pleasanton, California. Under this award, 10X Genomics will provide their Dual Gene Expression and Chromatin Profiling Kit to support analysis of olfactory epithelial regeneration through single nuclei capture and sequencing library generation. The kit will allow the NIH to profile gene expression and...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $30,539 firm fixed price purchase order to 10X Genomics, Inc. for the acquisition of Chromium Next GEM Single Cell 5' Kits and Library Construction Kits. Under the terms of the contract, 10X Genomics will provide 16 reactions of the Chromium Next GEM Single Cell 5' Kit v2 and 48 reactions of the Library Construction Kit. The place of performance is 10X...
This firm fixed price purchase order was awarded by the National Institute on Aging (NIA), part of the U.S. Department of Health and Human Services, to 10X Genomics, Inc. for $80,019.05. The contract is for single-cell multiomic assays to be used to map the epigenetic and transcriptomic signatures in peripheral blood mononuclear cells from participants in the Baltimore Longitudinal Study on Aging. This work aims to identify peripheral signatures that could predict the onset of cognitive...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to 10X Genomics, Inc., a life sciences technology company, for $128,562.00. The order is for 10X Genomics' products and services, including 10X Genomics' Chromium Next GEM Single Cell 5' Kits, 5' Feature Barcode Kits, Chromium Next GEM Chip G Single Cell Kits, Chromium Single Cell Human BCR and TCR Amplification Kits, and...
The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $19,821 firm fixed price blanket purchase agreement call contract to 10X Genomics, Inc. for chromium next generation cells, barcode kits, and dual index kits needed to complete single-cell sequencing analysis. The products will be delivered from 10X Genomics' location in Pleasanton, California to support the NIH NINDS's research efforts over a three month...

This firm fixed price purchase order was awarded by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to 10X Genomics, Inc. for $120,940.30. The contract calls for the delivery of 10X Genomics kits to conduct single cell gene product analysis of immune repertoire profiling of patient samples from the NIH's Clinical Myalgic Encephalomyelitis/Encephalopathy and Chronic Fatigue Syndrome trial. Place of performance will be 10X Genomics' facilities in Pleasanton, California, with work to be completed between August 9 and September 9, 2023. No subcontractors or set aside designations were identified. The award appears to support the NIH's ongoing clinical research efforts to advance understanding of myalgic encephalomyelitis/chronic fatigue syndrome.

Generated 12/22/23, 3:08 PM